. 2024 Feb 15;109(7):2219–2228. doi: 10.3324/haematol.2023.284089
Copyright© 2024 Ferrata Storti Foundation
This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
Table 1.
Treatment schedule in the clinical trial GEM-Selibordara.
